Pharma, not high-tech, concerns now dominate US patent politics
IAM Magazine
APRIL 30, 2022
The first pronouncements from new USPTO Director Kathi Vidal are the latest indication that the centre of gravity in IP debate and policy-making has shifted significantly.
Let's personalize your content